Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: a randomized, controlled trial
Spanemberg JC, López López J, de Figueiredo MA, Cherubini K, Salum FG
Journal of biomedical optics · 45 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Gobierno
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Según 2 financiadores declarados.
Publicación
- Publicado
- 2015-09-11 · J Biomed Opt · vol. 20 · número 9 · pág. 098001
- Editorial
- SPIE
- Citado
- 73 citas · más que el 85% de estudios similares · 1.8× el promedio de su campo
- Referencias
- 40 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Salivary Gland Disorders and Functions · Laser Applications in Dentistry and Medicine
- Palabras clave
- Randomized controlled trial, Low level laser therapy, Burning mouth syndrome, Medicine, Laser therapy, Dentistry, Laser, Internal medicine, Optics, Physics
- MeSH
- humans, burning mouth syndrome, pain measurement, aged, middle aged, female, male, low-level light therapy
5 autores
- Juliana Cassol Spanemberg🇧🇷Pontifícia Universidade Católica do Rio Grande do Sul
- José López López🇪🇸Bellvitge University Hospital; Universitat de Barcelona
- Maria Antonia Zancanaro de Figueiredo🇧🇷Pontifícia Universidade Católica do Rio Grande do Sul
- Karen Cherubini🇧🇷Pontifícia Universidade Católica do Rio Grande do Sul
- Fernanda Gonçalves Salum🇧🇷Pontifícia Universidade Católica do Rio Grande do Sul
Resumen
El texto original del estudio, en el idioma en que se publicó.
The aim of the present study was to assess the effect of low-level laser therapy (LLLT) in the treatment of burning mouth syndrome (BMS). A diode laser was used in 78 BMS patients who were randomly assigned into four groups: IR1W, n = 20 (830 nm, 100 mW, 5 J, 176 J/cm2, 50 s, LLLT weekly sessions, 10 sessions); IR3W, n = 20 (830 nm, 100 mW, 5 J, 176 J/cm2, 50 s, three LLLT weekly sessions, 9 sessions); red laser, n = 19 (685 nm, 35 mW, 2 J, 72 J/cm2, 58 s, three LLLT weekly sessions, 9 sessions); and control-group (CG), n = 19. Symptoms were assessed at the end of the treatment and eight weeks later; quality of life related to oral health was assessed using the Oral Health Impact Profile (OHIP-14). Statistical analysis was carried out using repeated measures analysis of variance followed by the posthoc Tukey test. There was significant reduction of the symptoms in all groups at the end of the treatment, which was maintained in the follow-up. The scores of the IR1W and IR3W laser groups differed significantly from those of the CG. There was also a decrease in the OHIP-14 scores in the four groups. The IR3W laser group scores differed significantly from those of the CG. LLLT reduces the symptoms of BMS and may be an alternative therapeutic strategy for the relief of symptoms in patients with BMS.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.